Stockreport

Beam Therapeutics upgraded to Outperform from Market Perform at Leerink [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF The firm notes that prior to Tuesday's BEAM-101 data in sickle-cell disease, risk of a safety signal kept Leerink on the sidelines. Following disclosure of a patient dea [Read more]